The pharmaceutical industry theory that depression is due to lack of serotonin chemical in the brain. This has been studied for decades, and has been shown to be incorrect. The theory of prescribing serotonin uptake inhibiters to treat depression as simply over-dosed unknowing people for decades. Ongoing use of a treatment which does not work, and which has side effects, is malpractice and fraud.
After decades of research, there remains no clear evidence that serotonin levels or serotonin activity are responsible for depression, according to a comprehensive review of prior research led by University College London (UCL) scientists.
The major new umbrella review – an overview of existing meta-analyses and systematic reviews – was published on July 20 in the journal Molecular Psychiatry. It suggests that depression is not likely caused by a chemical imbalance, and calls into question what antidepressant medications do. This is because most antidepressants are selective serotonin reuptake inhibitors (SSRIs), which were originally said to function by correcting abnormally low serotonin levels. In fact, there is no other accepted pharmacological mechanism by which antidepressants affect the symptoms of depression.
Lead author Professor Joanna Moncrieff, a Professor of Psychiatry at UCL and a consultant psychiatrist at North East London NHS Foundation Trust (NELFT), said: “It is always difficult to prove a negative, but I think we can safely say that after a vast amount of research conducted over several decades, there is no convincing evidence that depression is caused by serotonin abnormalities, particularly by lower levels or reduced activity of serotonin.
...
No comments:
Post a Comment